Publications
Print PDF
Positive EMA Opinions Could Bode Well For US Approvals of Biosimilars
September 7, 2016
Stacie Ropka, PhD
The Pharma Letter

Axinn counsel Stacie Ropka co-authored the article, "Positive EMA Opinions Could Bode Well For US Approvals of Biosimilars," for The Pharma Letter

Click here to access the article. A subscription is required. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.